FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
Article in Frontiers in Oncology (November 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (November 2023)
Article in Targeted Oncology (September 2023)
Book chapter (September 2023)